AIO-SUP-0119ass
Quality assurance on diagnosis and therapy of secondary immunodeficiencies (SID) in patients with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) in Germany [QS-SID)
I
nicht-interventionell (Register, Metaanalyse)
International
n/a
Status: Rekrutierung beendet
Zeitraum
2019
2020
Zentren
100
Keine Zentren gesucht
Patienten
1200
1086
14.04.2022
Identifier
AIO-SUP-0119ass
AIO-SUP-0119ass
Kontakt
Leitung
Prof. Dr. med. Hartmut Link
Ansprechpartner*in
AIO-Studien-gGmbH
E-Mail info@aio-studien-ggmbh.de